Alexander Krupp

Alexander Krupp, PhD, is Vice President and Executive Clinical Program Excellence Lead at Bayer AG, where he oversees product development while leveraging digital transformation to drive excellence in all aspects of research, design and clinical development.

As a molecular oncologist and neurophysiologist, Alexander has led computational life science and clinical innovation organizations, bridging AI, data strategy, and evidence generation in pharmaceutical R&D. He is a frequent keynote speaker at international industry events on topics including AI adoption in clinical trials, high-performance operating models, and the intersection of scientific method with digital execution. Alexander’s work focuses on strengthening decision quality and accountability in complex clinical programs through disciplined integration of advanced analytics, automation, and cross-disciplinary collaboration. His perspective combines a passion of people and scientific rigor with strategic leadership, making him a leading voice on how large R&D organizations operationalize AI-enabled workflows while maintaining governance and reliability in regulated research environments.